Integrin antagonists
US10703752B2 · kind B2 · utility
0Cited by
1References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 19, 2019 |
| Grant date | Jul 7, 2020 |
| Priority date | — |
| Expiry date | Aug 19, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel integrin antagonists of Formula I and their use as a medicament, in particular for inhibiting neovascularization.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.